Yutrepia™ (treprostinil)
for Pulmonary Arterial Hypertension

Yutrepia™ (treprostinil) is indicated for patients with pulmonary arterial hypertension (WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (WHO Group 3). Yutrepia is a prostacyclin mimetic that functions as a vasodilator, relaxing and widening blood vessels. This improves blood flow through the lungs, reducing heart strain and alleviating symptoms like shortness of breath and tiredness.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Pulmonary Arterial Hypertension - PAH